Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2025-12-24 @ 6:40 PM
NCT ID:
NCT03049657
Eligibility Criteria:
Inclusion Criteria:
* Patients with clinical or subclinical ischemic heart disease with indication of percutaneous revascularization.
* "De Novo" lesions ≥ 70%
* Reference diameters ≥ 2 mm and ≤ 4 mm Accepted participation in the registration with the signing of informed consent
Exclusion Criteria:
* Cardiogenic shock
* Pregnancy
* Intolerance or allergy to anti platelet or anticoagulant therapy
* Elective surgical procedure scheduled within 6 months after inclusion in the study
* Expectancy of life of less than 1 year.
* Impossibility of doing 1 year clinical follow-up.
* Primary angioplasty in patients with killip class III-IV or mechanical complications.
* Patient with pre-procedure restenosis.
* Patients who will not be treated all lesions with the Angiolite stent.
* Total occlusions
* Truncus disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03049657
Study Brief:
Protocol Section:
NCT03049657